<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01320475</url>
  </required_header>
  <id_info>
    <org_study_id>2009/04</org_study_id>
    <nct_id>NCT01320475</nct_id>
  </id_info>
  <brief_title>Epidural Levobupivacaine-sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine</brief_title>
  <official_title>Thoracic Epidural Analgesia: Epidural Levobupivacaine and Sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thoracic epidural analgesia is often proposed to thoracotomized patients. A local anesthetic
      and an opioid are generally associated to produce an epidural analgesia. However, opioid
      epidural administration is frequently associated with adverse effects as nausea, vomiting,
      urinary retention, ... On the other hand, iv ketamine has been demonstrated to be an
      effective analgesic.

      The purpose of the study is to compare the epidural administration of levobupivacaine and
      sufentanil or the epidural administration of levobupivacaine associated with the iv
      administration of ketamine.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty of Recruitment
  </why_stopped>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of an adverse event due to the analgesic protocol</measure>
    <time_frame>one week</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy of the analgesic regimen</measure>
    <time_frame>third postoperative day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative rehabilitation</measure>
    <time_frame>two weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications (pulmonary, others)</measure>
    <time_frame>one month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay</measure>
    <time_frame>one month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient's satisfaction</measure>
    <time_frame>sortie de l'hopital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurence of a chronic pain</measure>
    <time_frame>end the first postoperative year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Thoracic Surgery</condition>
  <arm_group>
    <arm_group_label>iv Ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural infusion of levobupivacaine and saline (placebo for sufentanil)and iv infusion of ketamine Up to the third postoperative day (6 PM)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sufentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Epidural infusion of levobupivacaine (1,25 mg/ml) and sufentanil(1 ml = 50 µg diluted in the 200 ml bag of levobupivacaine) IV infusion of saline (placebo for ketamine)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanil</intervention_name>
    <description>Epidural infusion of levobupivacaine (1,25 mg/ml) and sufentanil(1 ml = 50 µg diluted in the 200 ml bag of levobupivacaine) IV infusion of saline (placebo for ketamine)</description>
    <arm_group_label>Sufentanil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Epidural infusion of levobupivacaine (1,25 mg/ml) and saline (1 ml = 50 µg diluted in the 200 ml bag of levobupivacaine) IV infusion of ketamine (2 µg/kg/minute) Up to the third postoperative day (6 PM)</description>
    <arm_group_label>iv Ketamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 18 and 75 yrs

          -  class ASA I, II or III

          -  lung surgery

        Exclusion Criteria:

          -  Contra-indication to the achievement of epidural analgesia

          -  Preoperative chronic pain,

          -  Contra-indication to ketamine

          -  Hypersensitivity to ketamine or any excipients

          -  Uncontrolled hypertension,

          -  Stroke

          -  Heart failure

          -  Hepatic porphyria

          -  Contra-indication to sufentanil

          -  Hypersensitivity to sufentanil, opioids or any excipients

          -  Treatment with an opioid agonist-antagonist,

          -  Contra-indication to levobupivacaine

          -  Hypersensitivity to levobupivacaine, local anesthetics of the amide or any excipients

          -  Hypotension, shock
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2011</study_first_submitted>
  <study_first_submitted_qc>March 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2011</study_first_posted>
  <last_update_submitted>September 22, 2016</last_update_submitted>
  <last_update_submitted_qc>September 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thoracic epidural analgesia</keyword>
  <keyword>epidural opioid</keyword>
  <keyword>ketamine</keyword>
  <keyword>adverse effect</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

